Immunologic characterization of a immunosuppressed multiple sclerosis patient that recovered from SARS-CoV-2 infection

A multiple sclerosis patient infected by SARS-CoV-2 during fingolimod therapy was hospitalized with moderate clinical features, and recovered in 15 days. High levels of CCL5 and CCL10 chemokines and of antibody-secreting B cells were detected, while the levels other B- and T-cell subsets were compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Chiarini, Marco, Paghera, Simone, Moratto, Daniele, Rossi, Nicola De, Giacomelli, Mauro, Badolato, Raffaele, Capra, Ruggero, Imberti, Luisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256606/
https://www.ncbi.nlm.nih.gov/pubmed/32505908
http://dx.doi.org/10.1016/j.jneuroim.2020.577282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7256606/
https://www.ncbi.nlm.nih.gov/pubmed/32505908
http://dx.doi.org/10.1016/j.jneuroim.2020.577282

Ejemplares similares